Döhner K - Search Results

1

Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.

Bhayadia R, Krowiorz K, Haetscher N, Jammal R, Emmrich S, Obulkasim A, Fiedler J, Schwarzer A, Rouhi A, Heuser M, Wingert S, Bothur S, Döhner K, Mätzig T, Ng M, Reinhardt D, Döhner H, Zwaan CM, van den Heuvel Eibrink M, Heckl D, Fornerod M, Thum T, Humphries RK, Rieger MA, Kuchenbauer F, Klusmann JH. Bhayadia R, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. Epub 2018 Feb 12. J Clin Oncol. 2018. PMID: 29432078

2

Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact.

Döhner K, Schlenk RF, van der Reijden BA, Döhner H. Döhner K, et al. Among authors: dohner h. Leukemia. 2000 Jun;14(6):1154. doi: 10.1038/sj.leu.2401804. Leukemia. 2000. PMID: 10865983 No abstract available.

3

Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.

Fröhling S, Nakabayashi K, Scherer SW, Döhner H, Döhner K. Fröhling S, et al. Among authors: dohner k, dohner h. Hum Genet. 2001 Apr;108(4):304-9. doi: 10.1007/s004390100498. Hum Genet. 2001. PMID: 11379876

4

Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.

Fröhling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Döhner H, Döhner K; Acute Myeloid Leukemia Study Group, Ulm. Fröhling S, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2002 May 15;20(10):2480-5. doi: 10.1200/JCO.2002.08.155. J Clin Oncol. 2002. PMID: 12011125

5

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

Döhner K, Tobis K, Ulrich R, Fröhling S, Benner A, Schlenk RF, Döhner H. Döhner K, et al. Among authors: dohner h. J Clin Oncol. 2002 Aug 1;20(15):3254-61. doi: 10.1200/JCO.2002.09.088. J Clin Oncol. 2002. PMID: 12149299 Clinical Trial.

6

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K; AML Study Group Ulm. Acute myeloid leukemia. Fröhling S, et al. Among authors: dohner k, dohner h. Blood. 2002 Dec 15;100(13):4372-80. doi: 10.1182/blood-2002-05-1440. Epub 2002 Aug 8. Blood. 2002. PMID: 12393388 Free article.

7

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.

Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, Fischer JT, Gunzer U, Pezzutto A, Weber W, Grimminger W, Preiss J, Hensel M, Fröhling S, Döhner K, Haas R, Döhner H; AML Study Group Ulm (AMLSG ULM). Schlenk RF, et al. Among authors: dohner k, dohner h. Leukemia. 2003 Aug;17(8):1521-8. doi: 10.1038/sj.leu.2403009. Leukemia. 2003. PMID: 12886238 Clinical Trial.

8

Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.

Scholl C, Breitinger H, Schlenk RF, Döhner H, Fröhling S, Döhner K; AML Study Group Ulm. Scholl C, et al. Among authors: dohner k, dohner h. Genes Chromosomes Cancer. 2003 Nov;38(3):274-80. doi: 10.1002/gcc.10284. Genes Chromosomes Cancer. 2003. PMID: 14506704

9

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Fröhling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K. Fröhling S, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2004 Feb 15;22(4):624-33. doi: 10.1200/JCO.2004.06.060. Epub 2004 Jan 15. J Clin Oncol. 2004. PMID: 14726504

10

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R, Döhner H, Pollack JR. Bullinger L, et al. Among authors: dohner k, dohner h. N Engl J Med. 2004 Apr 15;350(16):1605-16. doi: 10.1056/NEJMoa031046. N Engl J Med. 2004. PMID: 15084693 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page